vs

Side-by-side financial comparison of California BanCorp \ CA (BCAL) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

California BanCorp \ CA is the larger business by last-quarter revenue ($45.9M vs $41.8M, roughly 1.1× Neuronetics, Inc.). California BanCorp \ CA runs the higher net margin — 35.8% vs -17.2%, a 53.0% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 0.8%). California BanCorp \ CA produced more free cash flow last quarter ($56.9M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 44.7%).

Pacific Premier Bancorp, Inc. is an American bank holding company under the Bank Holding Company Act of 1956 headquartered in Irvine, California, US. Its principal business focuses on Pacific Premier Bank, which offers a range of financial services to individuals, businesses, and professionals. The bank operates numerous branches in California, Arizona, Nevada, and Washington.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

BCAL vs STIM — Head-to-Head

Bigger by revenue
BCAL
BCAL
1.1× larger
BCAL
$45.9M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+85.0% gap
STIM
85.7%
0.8%
BCAL
Higher net margin
BCAL
BCAL
53.0% more per $
BCAL
35.8%
-17.2%
STIM
More free cash flow
BCAL
BCAL
$56.3M more FCF
BCAL
$56.9M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
44.7%
BCAL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCAL
BCAL
STIM
STIM
Revenue
$45.9M
$41.8M
Net Profit
$16.4M
$-7.2M
Gross Margin
52.0%
Operating Margin
48.8%
-12.1%
Net Margin
35.8%
-17.2%
Revenue YoY
0.8%
85.7%
Net Profit YoY
-2.1%
43.2%
EPS (diluted)
$0.50
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCAL
BCAL
STIM
STIM
Q4 25
$45.9M
$41.8M
Q3 25
$45.2M
$37.3M
Q2 25
$44.3M
$38.1M
Q1 25
$44.8M
$32.0M
Q4 24
$45.5M
$22.5M
Q3 24
$38.1M
$18.5M
Q2 24
$22.2M
$16.4M
Q1 24
$21.9M
$17.4M
Net Profit
BCAL
BCAL
STIM
STIM
Q4 25
$16.4M
$-7.2M
Q3 25
$15.7M
$-9.0M
Q2 25
$14.1M
$-10.1M
Q1 25
$16.9M
$-12.7M
Q4 24
$16.8M
$-12.7M
Q3 24
$-16.5M
$-13.3M
Q2 24
$190.0K
$-9.8M
Q1 24
$4.9M
$-7.9M
Gross Margin
BCAL
BCAL
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
BCAL
BCAL
STIM
STIM
Q4 25
48.8%
-12.1%
Q3 25
48.3%
-19.6%
Q2 25
45.3%
-21.1%
Q1 25
52.8%
-34.4%
Q4 24
52.2%
-51.0%
Q3 24
-59.1%
-41.7%
Q2 24
1.3%
-51.7%
Q1 24
33.1%
-39.4%
Net Margin
BCAL
BCAL
STIM
STIM
Q4 25
35.8%
-17.2%
Q3 25
34.7%
-24.3%
Q2 25
31.8%
-26.6%
Q1 25
37.6%
-39.6%
Q4 24
37.7%
-56.4%
Q3 24
-43.2%
-72.0%
Q2 24
0.9%
-59.8%
Q1 24
22.5%
-45.2%
EPS (diluted)
BCAL
BCAL
STIM
STIM
Q4 25
$0.50
$-0.10
Q3 25
$0.48
$-0.13
Q2 25
$0.43
$-0.15
Q1 25
$0.52
$-0.21
Q4 24
$0.54
$-0.34
Q3 24
$-0.59
$-0.44
Q2 24
$0.01
$-0.33
Q1 24
$0.26
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCAL
BCAL
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$399.9M
$28.1M
Total DebtLower is stronger
$33.8M
$65.8M
Stockholders' EquityBook value
$576.6M
$22.4M
Total Assets
$4.0B
$141.6M
Debt / EquityLower = less leverage
0.06×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCAL
BCAL
STIM
STIM
Q4 25
$399.9M
$28.1M
Q3 25
$559.2M
$28.0M
Q2 25
$430.1M
$11.0M
Q1 25
$439.2M
$20.2M
Q4 24
$388.2M
$18.5M
Q3 24
$614.4M
$20.9M
Q2 24
$104.7M
$42.6M
Q1 24
$86.5M
$47.7M
Total Debt
BCAL
BCAL
STIM
STIM
Q4 25
$33.8M
$65.8M
Q3 25
$33.4M
$65.7M
Q2 25
$52.9M
$55.5M
Q1 25
$70.3M
$55.3M
Q4 24
$69.7M
$55.2M
Q3 24
$69.1M
$46.0M
Q2 24
$42.9M
$59.8M
Q1 24
$44.9M
$59.4M
Stockholders' Equity
BCAL
BCAL
STIM
STIM
Q4 25
$576.6M
$22.4M
Q3 25
$564.7M
$27.4M
Q2 25
$547.6M
$27.1M
Q1 25
$531.4M
$35.5M
Q4 24
$511.8M
$27.7M
Q3 24
$498.1M
$9.4M
Q2 24
$293.2M
$19.4M
Q1 24
$292.5M
$27.7M
Total Assets
BCAL
BCAL
STIM
STIM
Q4 25
$4.0B
$141.6M
Q3 25
$4.1B
$145.5M
Q2 25
$4.0B
$134.7M
Q1 25
$4.0B
$142.0M
Q4 24
$4.0B
$140.9M
Q3 24
$4.4B
Q2 24
$2.3B
$96.8M
Q1 24
$2.3B
$103.8M
Debt / Equity
BCAL
BCAL
STIM
STIM
Q4 25
0.06×
2.94×
Q3 25
0.06×
2.40×
Q2 25
0.10×
2.05×
Q1 25
0.13×
1.56×
Q4 24
0.14×
1.99×
Q3 24
0.14×
4.90×
Q2 24
0.15×
3.08×
Q1 24
0.15×
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCAL
BCAL
STIM
STIM
Operating Cash FlowLast quarter
$57.3M
$908.0K
Free Cash FlowOCF − Capex
$56.9M
$692.0K
FCF MarginFCF / Revenue
124.1%
1.7%
Capex IntensityCapex / Revenue
0.8%
0.5%
Cash ConversionOCF / Net Profit
3.49×
TTM Free Cash FlowTrailing 4 quarters
$93.1M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCAL
BCAL
STIM
STIM
Q4 25
$57.3M
$908.0K
Q3 25
$16.0M
$-785.0K
Q2 25
$13.4M
$-3.5M
Q1 25
$7.0M
$-17.0M
Q4 24
$50.3M
$-8.6M
Q3 24
$18.3M
$-5.4M
Q2 24
$309.0K
$-5.0M
Q1 24
$8.1M
$-12.0M
Free Cash Flow
BCAL
BCAL
STIM
STIM
Q4 25
$56.9M
$692.0K
Q3 25
$15.9M
$-899.0K
Q2 25
$13.4M
$-3.8M
Q1 25
$6.9M
$-17.2M
Q4 24
$49.7M
$-8.7M
Q3 24
$18.1M
$-5.8M
Q2 24
$171.0K
$-5.6M
Q1 24
$8.0M
$-12.4M
FCF Margin
BCAL
BCAL
STIM
STIM
Q4 25
124.1%
1.7%
Q3 25
35.1%
-2.4%
Q2 25
30.2%
-9.9%
Q1 25
15.3%
-53.8%
Q4 24
109.2%
-38.6%
Q3 24
47.5%
-31.3%
Q2 24
0.8%
-34.0%
Q1 24
36.4%
-71.1%
Capex Intensity
BCAL
BCAL
STIM
STIM
Q4 25
0.8%
0.5%
Q3 25
0.2%
0.3%
Q2 25
0.1%
0.7%
Q1 25
0.2%
0.7%
Q4 24
1.2%
0.4%
Q3 24
0.5%
2.1%
Q2 24
0.6%
3.7%
Q1 24
0.4%
2.2%
Cash Conversion
BCAL
BCAL
STIM
STIM
Q4 25
3.49×
Q3 25
1.02×
Q2 25
0.95×
Q1 25
0.41×
Q4 24
3.00×
Q3 24
Q2 24
1.63×
Q1 24
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons